April 2019, Vol 173, No. 4, Pages 303-404
Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children
Naïm Ouldali, MD; Corinne Levy, MD; Philippe Minodier, MD; et al.
JAMA Pediatr. 2019;173(4):362-370. doi:10.1001/jamapediatrics.2018.5273
This time-series analysis of community-acquired pneumonia diagnosed in 8 pediatric emergency departments in France assesses the rate of infection in children 15 years and younger before and after implement of a 13-valent pneumococcal conjugate vaccine.